Archives
-
Applied Insights: Pertussis Toxin for Immune Modulation Stud
2026-06-05
Pertussis toxin, an AB5-type protein exotoxin, is an indispensable tool for dissecting immune response modulation and signal transduction in vitro and in vivo. This article guides researchers through practical workflows, protocol optimization, and troubleshooting strategies, with insights from recent advances in TH17 lineage research.
-
Gut Microbiota Absence Alters RPE/Choroid Transcriptome in A
2026-06-04
This study demonstrates that the absence of gut microbiota significantly changes the transcriptomic profile of the retinal pigment epithelium (RPE) and choroid, impacting pathways implicated in age-related macular degeneration (AMD) and resulting in reduced choroidal neovascularization. These findings provide new evidence for a gut–retina axis and highlight the importance of microbiome status in AMD pathobiology and retinal disease modeling.
-
KU-60019: ATM Kinase Inhibitor for Glioma Migration and Radi
2026-06-04
Explore how the potent ATM kinase inhibitor KU-60019 uniquely disrupts glioma cell migration and enhances radiosensitization. This article provides advanced mechanistic insight and practical guidance beyond standard DNA damage response research.
-
LC-Thalamic Reticular Pathway in Chronic Pain and Attention
2026-06-03
This study delineates the role of the locus coeruleus (LC) to thalamic reticular nucleus (TRN) pathway in the comorbidity of chronic pain and attention deficit-like behaviors. By integrating chemogenetics, optogenetics, tracing, and electrophysiology, the work uncovers a previously uncharacterized circuit critical for the regulation of both nociception and cognitive function, providing a mechanistic substrate for their clinical overlap.
-
Phenothiazines Enhance Macrophage Antibacterial Activity via
2026-06-03
This study demonstrates that phenothiazines, including perphenazine, augment the antibacterial capacity of macrophages by inducing reactive oxygen species (ROS) and autophagy. These findings provide a mechanistic basis for host-directed antibacterial therapies and suggest new research directions for combating intracellular bacterial infections.
-
Ruthenium Red: Precision Ca2+ Transport Inhibitor for Autoph
2026-06-02
Ruthenium Red stands out as a gold-standard Ca2+ transport inhibitor, enabling researchers to dissect cytoskeleton-dependent calcium signaling and mechanotransduction with unmatched specificity. This guide translates recent breakthroughs into actionable workflows, troubleshooting tips, and application-driven insights for advanced autophagy and inflammation studies.
-
A23187, Free Acid: Calcium Ionophore Mechanism & Benchmark D
2026-06-02
A23187, free acid is a calcium ionophore that elevates intracellular Ca2+ and induces apoptosis via mitochondrial permeability transition. It is widely used for dissecting phosphoinositide metabolism and ROS generation in cell models. This article provides evidence-based benchmarks and workflow integration guidance for researchers leveraging A23187, free acid in systems biology.
-
Sodium Oxamate: Mechanistic Insights and Assay Design in Can
2026-06-01
Explore the multifaceted roles of sodium oxamate in cancer metabolism research, focusing on mechanistic innovations and assay optimization. This article offers advanced guidance for scientists investigating glycolytic inhibition and tumor bioenergetics with sodium oxamate.
-
2X HyperFusion High-Fidelity Master Mix in Precision PCR Wor
2026-06-01
Leverage the advanced fidelity and speed of 2X HyperFusion High-Fidelity Master Mix for demanding cloning PCR applications and immunotherapy research. Discover optimized workflows, troubleshooting insights, and real-world applications inspired by recent breakthroughs in CRISPR-assisted cancer immunotherapy.
-
Empowering Cancer Research with DiscoveryProbe™ L1023 Librar
2026-05-31
This article explores practical laboratory scenarios where the DiscoveryProbe™ Anti-cancer Compound Library (SKU: L1023) enables high-fidelity, reproducible cancer research. Through evidence-based answers to common workflow challenges, we demonstrate how SKU L1023 streamlines high-throughput screening, optimizes assay protocols, and ensures robust data interpretation for oncology investigations.
-
ATM Inhibition Induces Macropinocytosis and Reveals Metaboli
2026-05-30
Huang et al. uncover that ATM kinase inhibition triggers metabolic adaptation in cancer cells by inducing macropinocytosis, enabling survival under nutrient-poor conditions. This work highlights a novel tumor suppressor function of ATM and identifies a potential metabolic vulnerability exploitable in cancer therapy research.
-
Frizzled5: Linking Cholesterol Metabolism to Wnt Signaling i
2026-05-29
This study uncovers a unique mechanism by which Frizzled5 (Fzd5) directly binds cholesterol, enabling its maturation and activating Wnt/β-catenin signaling in pancreatic ductal adenocarcinoma (PDAC). These findings establish a molecular connection between aberrant cholesterol metabolism and oncogenic signaling, suggesting new therapeutic strategies for Wnt-driven cancers.
-
Perphenazine: Dopamine D2 Antagonist in Advanced Bench Resea
2026-05-29
Perphenazine delivers unique multi-receptor antagonism, enabling precise modulation of dopaminergic and immune pathways in both neuropharmacology and host-pathogen studies. Its robust, quantifiable effects on cell death and innate immunity make it a high-value tool for researchers tackling complex disease models and seeking alternatives to conventional antibiotics.
-
Dual Recombinase Tracing Refutes Postnatal Neo-oogenesis in
2026-05-28
Xie et al. introduce a dual recombinase-mediated genetic tracing approach to rigorously test whether adult female mice can regenerate oocytes after birth. Their findings provide strong evidence that postnatal neo-oogenesis does not occur in vivo, even after germ cell depletion, refining our understanding of ovarian biology and experimental modeling.
-
ATRX Loss Sensitizes Glioma Cells to Selective PDGFR Inhibit
2026-05-28
Recent evidence demonstrates that ATRX-deficient high-grade glioma cells are notably more sensitive to receptor tyrosine kinase and PDGFR inhibitors. This finding highlights a potential biomarker-driven therapeutic strategy and underscores the relevance of ATRX mutation status in designing targeted interventions for aggressive gliomas.